Microglia activation due to obesity programs metabolic failure leading to type two diabetes

Nutrition and Diabetes

Volumn 7, Issue 3, 2017, Pages

  Maldonado Ruiz, R ^a   Montalvo Martinez L ^a   Fuentes Mera, L ^a   Camacho, A ^a  

^a UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CRYOPYRIN; FIBRINOGEN; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; SERUM AMYLOID A; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR;

ADIPOSE TISSUE; BRAIN FUNCTION; CHRONIC INFLAMMATION; COGNITIVE DEFECT; HOMEOSTASIS; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; LIPOTOXICITY; METABOLIC SYNDROME X; MICROGLIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; BRAIN; METABOLISM;

BRAIN; DIABETES MELLITUS, TYPE 2; HUMANS; INFLAMMATION; MICROGLIA; OBESITY;

EID: 85026663034     PISSN: None     EISSN: 20444052     Source Type: Journal    
DOI: 10.1038/nutd.2017.10     Document Type: Review

References (105)

1. Virtue S, Vidal-Puig A. It's not how fat you are, it's what you do with it that counts. PLoS Biol 2008; 6: e237.
2. NCD Risk Factor Collaboration. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet 2016; 387: 1377-1396.
3. Vidal-Puig A. Adipose tissue expandability, lipotoxicity and the metabolic syndrome. Endocrinol Nutr 2013; 60: 39-43.
4. Virtue S, Vidal-Puig A. Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome-an allostatic perspective. Biochim Biophys Acta 2010; 1801: 338-349.
5. Adams JM, Pratipanawatr T, Berria R, Wang E, DeFronzo RA, Sullards MC et al. Ceramide content is increased in skeletal muscle from obese insulinresistant humans. Diabetes 2004; 53: 25-31.
6. Drobnik W, Liebisch G, Audebert FX, Frohlich D, Gluck T, Vogel P et al. Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients. J Lipid Res 2003; 44: 754-761.
7. Kitessa SM, Abeywardena MY. Lipid-induced insulin resistance in skeletal muscle: the chase for the culprit goes from total intramuscular fat to lipid intermediates, and finally to species of lipid intermediates. Nutrients 2016; 8: E466.
8. Pietiläinen KH, Róg T, Seppänen-Laakso T, Virtue S, Gopalacharyulu P, Tang J et al. Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans. PLoS Biol 2011; 9: e1000623.
9. Kotronen A, Velagapudi VR, Yetukuri L, Westerbacka J, Bergholm R, Ekroos K et al. Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations. Diabetologia 2009; 52: 684-690.
10. Ussher JR, Koves TR, Cadete VJ, Zhang L, Jaswal JS, Swyrd SJ et al. Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption. Diabetes 2010; 59: 2453-2464.
11. Haffner SM. Relationship of metabolic risk factors and development of cardiovascular disease and diabetes. Obesity 2006; 14: 121S-127S.
12. Chaurasia B, Summers SA. Ceramides-lipotoxic inducers of metabolic disorders. Trends Endocrinol Metab 2015; 26: 538-550.
13. Ertunc EM, Hotamisligil GS. Lipid signaling and lipotoxicity in metabolic inflammation: indications for metabolic disease pathogenesis and treatment. J Lipid Res 2016; 57: 2099-2114.
14. Schönfeld P, Reiser G. Brain lipotoxicity of phytanic acid and very long-chain fatty acids. harmful cellular/mitochondrial activities in refsum disease and X-linked adrenoleukodystrophy. Aging Dis 2016; 7: 136-149.
15. Zarrouk A, Nury T, Samadi M, O'Callaghan Y, Hammami M, O'Brien NM et al. Effects of cholesterol oxides on cell death induction and calcium increase in human neuronal cells (SK-N-BE) and evaluation of the protective effects of docosahexaenoic acid (DHA; C22:6 n-3). Steroids 2015; 99: 238-247.
16. Agrawal NK, Kant S. Targeting inflammation in diabetes: newer therapeutic options. World J Diabetes 2014; 5: 697-710.
17. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; 13: 785-789.
18. Miner JL. The adipocyte as an endocrine cell. J Animal Sci 2004; 82: 935-941.
19. Cohen P, Spiegelman BM. Cell biology of fat storage. Mol Biol Cell 2016; 27: 2523-2527.
20. Prieur X, Mok CY, Velagapudi VR, Núñez V, Fuentes L, Montaner D et al. Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice. Diabetes 2011; 60: 797-809.
21. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808.
22. Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest 2011; 121: 2111-2117.
23. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91.
24. Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 2003; 52: 1779-1785.
25. Kwon H, Pessin JE. Adipokines mediate inflammation and insulin resistance. Front Endocrinol 2013; 4: 71.
26. Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol 2009; 1: a001651.
27. Meshkani R, Vakili S. Tissue resident macrophages: Key players in the pathogenesis of type 2 diabetes and its complications. Clin Chim Acta 2016; 26: 77-89.
28. Minihane AM, Vinoy S, Russell WR, Baka A, Roche HM, Tuohy KM et al. Low-grade inflammation, diet composition and health: current research evidence and its translation. Br J Nutr 2015; 114: 999-1012.
29. Hotamisligil GS. Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes. Diabetes 2005; 54: S73-S78.
30. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006; 17: 4-12.
31. Maachi M, Pieroni L, Bruckert E, Jardel C, Fellahi S, Hainque B et al. Systemic lowgrade inflammation is related to both circulating and adipose tissue TNFalpha, leptin and IL-6 levels in obese women. Int J Obes Relat Metab Disord 2004; 28: 993-997.
32. Nonogak K, Fuller GM, Fuentes NL, Moser AH, Staprans I, Grunfeld C et al. Interleukin-6 stimulates hepatic triglyceride excretion in fats. Endocrinology 1995; 136: 2143-2149.
33. Nijmeijer R, Lagrand WK, Lubbers YTP, Visser CA, CJLM Meijer, Niessen HWM et al. C-Reactive protein activates complement in infarcted human myocardium. Am J Pathol 2003; 163: 269-275.
34. Choi J, Joseph L, Pilote L. Obesity and C-reactive protein in various populations: a systematic review and meta-analysis. Obes Rev 2013; 14: 232-244.
35. Bing C. Is interleukin-1beta a culprit in macrophage-adipocyte crosstalk in obesity? Adipocyte 2015; 4: 149-152.
36. Owyang AM, Maedler K, Gross L, Yin J, Esposito L, Shu L et al. XOMA 052, an anti-IL-1{beta} monoclonal antibody, improves glucose control and {beta}-cell function in the diet-induced obesity mouse model. Endocrinology 2010; 151: 2515-2257.
37. Shirasuna K, Takano H, Seno K, Ohtsu A, Karasawa T, Takahashi M et al. Palmitic acid induces interleukin-1β secretion via NLRP3 inflammasomes and inflammatory responses through ROS production in human placental cells. J Reprod Immunol 2016; 116: 104-112.
38. Alomar SY, Zaibi MS, Kepczynska MA, Gentili A, Alkhuriji A. Mansour L, et al. PCR array and protein array studies demonstrate that IL-1beta (interleukin-1beta) stimulates the expression and secretion of multiple cytokines and chemokines in human adipocytes. Arch Physiol Biochem 2015; 121: 187-193.
39. De Nardo D, Latz E. NLRP3 inflammasomes link inflammation and metabolic disease. Trends Immunol 2011; 32: 373-379.
40. Vandanmagsar B, Youm Y-H, Ravussin A, Galgani JE, Stadler K, Mynatt RL et al. The NALP3/NLRP3 inflammasome instigates obesity-induced autoinflammation and insulin resistance. Nat Med 2011; 17: 179-188.
41. Shah C, Yang G, Lee I, Bielawski J, Hannun YA, Samad F. Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1. J Biol Chem 2008; 283: 13538-13548.
42. Stienstra R, Joosten LAB, Koenen T, van Tits B, van Diepen JA, van den Berg SAA et al. The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab 2010; 12: 593-605.
43. Ruan H, Dong LQ. Adiponectin signaling and function in insulin target tissues. J. Mol Cell Biol 2016; 8: 101-109.
44. Lihn AS, Bruun JM, He G, Pedersen SB, Jensen PF, Richelsen B. Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol 2004; 219: 9-15.
45. Halleux CM, Takahashi M, Delporte ML, Detry R, Funahashi T, Matsuzawa Y et al. Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochem Biophys Res Commun 2001; 288: 1102-1107.
46. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001; 50: 2094-2099.
47. Chakraborti CK. Role of adiponectin and some other factors linking type 2 diabetes mellitus and obesity. World J Diabetes 2015; 6: 1296-1308.
48. Kaplan JL, Marshall MA, C McSkimming C, Harmon DB, Garmey JC, Oldham SN et al. Adipocyte progenitor cells initiate monocyte chemoattractant protein-1-mediated macrophage accumulation in visceral adipose tissue. Mol Metab 2015; 4: 779-794.
49. Xu L, Kitade H, Ni Y, Ota T. Roles of chemokines and chemokine receptors in obesity-associated insulin resistance and nonalcoholic fatty liver disease. Biomolecules 2015; 5: 1563-1579.
50. Kovacevic A, Hammer A, Stadelmeyer E, Windischhofer W, Sundl M, Ray A et al. Expression of serum amyloid A transcripts in human bone tissues, differentiated osteoblast-like stem cells and human osteosarcoma cell lines. J. Cell. Biochem 2008; 103: 994-1004.
51. Hagihara K, Nishikawa T, Isobe T, Song J, Sugamata Y, Yoshizaki K. IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform realtime quantitative RT-PCR assay system. Biochem. Biophys. Res. Commun 2004; 314: 363-369.
52. de Seny D, Cobraiville G, Charlier E, Neuville S, Esser N, Malaise D et al. Acutephase serum amyloid a in osteoarthritis: regulatory mechanism and proinflammatory properties. PLoS ONE 2013; 8: e66769.
53. Poitou C, Viguerie N, Cancello R, De Matteis R, Cinti S, Stich V et al. Serum amyloid A: production by human white adipocytes and regulation by obesity and nutrition. Diabetologia 2005; 48: 519-528.
54. Shishkova VN, Remennik AIu, Zotova LI. Development of main disturbances of hemostasis in patients with obesity. Kardiologia 2012; 52: 59-64.
55. Wake H, Moorhouse AJ, Miyamoto A, Nabekura J. Microglia: actively surveying and shaping neuronal circuit structure and function. Trends Neurosci 2013; 36: 209-217.
56. Schafer DP. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 2012; 74: 691-705.
57. Stevens B. The classical complement cascade mediates CNS synapse elimination. Cell 2007; 131: 1164-1178.
58. Zhan Y, Paolicelli RC, Sforazzini F, Weinhard L, Bolasco G, Pagani F et al. Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior. Nature Neuroscience 2014; 17: 400-406.
59. Zhang J, Malik A, Choi HB, Ko RW, Dissing-Olesen L, MacVicar BA. Microglial CR3 activation triggers long-term synaptic depression in the hippocampus via NADPH oxidase. Neuron 2014; 82: 195-207.
60. Lui H, Zhang J, Makinson SR, Cahill MK, Kelley KW, Huang HY et al. Progranulin deficiency promotes circuit-specific synaptic pruning by microglia via complement activation. Cell 2016; 165: 921-935.
61. Vasek MJ, Garber C, Dorsey D, Durrant DM, Bollman B, Soung A et al. A complement-microglial axis drives synapse loss during virus-induced memory impairment. Nature 2016; 534: 538-543.
62. Karch C, Jeng A, Nowotny P, Cady J, Cruchaga C, Goate A. Expression of novel Alzheimer's disease risk genes in control and alzheimer's disease brains. PLoS ONE 2012; 7: e50976.
63. Buckman LB, Hasty AL, Flaherty DK, Buckman CT, Thompson MM, Matlock BK et al. Obesity induced by a high-fat diet is associated with increased immune cell entry into the central nervous system. Brain Behav Immun 2014; 35: 33-42.
64. Kumar M, Roe K, Nerurkar PV, Orillo B, Thompson KS, Verma S et al. Reduced immune cell infiltration and increased pro-inflammatory mediators in the brain of Type 2 diabetic mouse model infected with West Nile virus. J Neuroinflammation 2014; 11: 80.
65. Arruda AP, Milanski M, Coope A, Torsoni AS, Ropelle E, Carvalho DP et al. Lowgrade hypothalamic inflammation leads to defective thermogenesis, insulin resistance, and impaired insulin secretion. Endocrinology 2011; 152: 1314-1326.
66. Calegari VC, Torsoni AS, Vanzela EC, Araújo EP, Morari J, Zoppi CC et al. Inflammation of the hypothalamus leads to defective pancreatic islet function. J Biol Chem 286: 12870-12880.
67. Milanski M, Arruda AP, Coope A, Ignacio-Souza LM, Nunez CE, Roman EA et al. Inhibition of hypothalamic inflammation reverses diet-induced insulin resistance in the liver. Diabetes 2012; 61: 1455-1462.
68. Pocai A, Lam TK, Gutierrez-Juarez R, Obici S, Schwartz GJ, Bryan J et al. Hypothalamic KATP channels control hepatic glucose production. Nature 2005; 434: 1026-1031.
69. Obici S, Zhang BB, Karkanias G, Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nature Medicine 2002; 8: 1376-1382.
70. Matteoli G, Gomez-Pinilla PJ, Nemethova A, Di Giovangiulio M, Cailotto C, van Bree SH et al. A distinct vagal anti-inflammatory pathway modulates intestinal muscularis resident macrophages independent of the spleen. Gut 2014; 63: 938-948.
71. Winer DA, Winer S, Shen L, Wadia PP, Yantha J, Paltser G et al. Lymphocytes promote insulin resistance through modulation of T lymphocytes and production of pathogenic IgG antibody. Nat Med 2011; 17: 610-617.
72. Valdearcos M, Robblee MM, Benjamin DI, Nomura DK, Xu AW, Koliwad SK. Microglia dictate the impact of saturated fat consumption on hypothalamic inflammation and neuronal function. Cell reports 2014; 9: 2124-2138.
73. Maric T, Woodside B, Luheshi GN. The effects of dietary saturated fat on basal hypothalamic neuroinflammation in rats. Brain Behav Immun 2014; 36: 35-45.
74. Sánchez-Sarasúa S, Moustafa S, García-Avilés Á, López-Climent MF, Gómez-Cadenas A, Olucha-Bordonau FE et al. The effect of abscisic acid chronic treatment on neuroinflammatory markers and memory in a rat model of high-fat diet induced neuroinflammation. Nutr Metab 2016; 13: 73.
75. Kang EB, Koo JH, Jang YC, Yang CH, Lee Y, Cosio-Lima LM et al. Neuroprotective effects of endurance exercise against high-fat diet-induced hippocampal neuroinflammation. J Neuroendocrinol 2016; 28: 1-10.
76. Cai G, Dinan T, Barwood JM, De Luca SN, Soch A, Ziko I et al. Neonatal overfeeding attenuates acute central pro-inflammatory effects of short-term high fat diet. Front Neurosci 2015; 8: 446.
77. Ziko I, De Luca S, Dinan T, Barwood JM, Sominsky L, Cai G et al. Neonatal overfeeding alters hypothalamic microglial profiles and central responses to immune challenge long-term. Brain Behav Immun 2014; 1: 32-43.
78. Thaler JP, Yi CX, Schur EA, Guyenet SJ, Hwang BH, Dietrich MO et al. Obesity is associated with hypothalamic injury in rodents and humans. J Clin Invest 2012; 122: 153-162.
79. Morari J, Anhe GF, Nascimento LF, de Moura RF, Razolli D, Solon C et al. Fractalkine (CX3CL1) is involved in the early activation of hypothalamic inflammation in experimental obesity. Diabetes 2014; 63: 3770-3784.
80. Tornatore L, Thotakura AK, Bennett J, Moretti M, Franzoso G. The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation. Trends Cell Biol 2012; 22: 557-566.
81. Maqbool A, Lattke M, Wirth T, Baumann B. Sustained, neuron-specific IKK/NF-κB activation generates a selective neuroinflammatory response promoting local neurodegeneration with aging. Mol Neurodegener 2013; 8: 40.
82. Wu Y, Yu Y, Szabo A, Han M, Feng Huang X. Central inflammation and leptin resistance are attenuated by ginsenoside rb1 treatment in obese mice fed a high-fat diet. PLoS ONE 2014; 9: e92618.
83. Posey KA, Clegg DJ, Printz RL, Byun J, Morton GJ, Vivekanandan-Giri A et al. Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet. Am J Physiol Endocrinol Metab 2009; 296: E1003-E1012.
84. Cai D. Neuroinflammation and neurodegeneration in overnutrition induced diseases. Trends Endocrinol Metab 2013; 24: 40-47.
85. Zhang X, Zhang G, Zhang H, Karin M, Bai H, Cai D. Hypothalamic IKKbeta/NFkappaB and ER stress link overnutrition to energy imbalance and obesity. Cell 2008; 135: 61-73.
86. Li J, Tang Y, Cai D. IKKbeta/NF-kappaB disrupts adult hypothalamic neural stem cells to mediate a neurodegenerative mechanism of dietary obesity and pre-diabetes. Nat Cell Biol 2012; 14: 999-1012.
87. Bonifati DM, Kishore U. Role of complement in neurodegeneration and neuroinflammation. Mol Immunol 2007; 44: 999-1010.
88. McNay DEG, Briancon N, Kokoeva MV, Maratos-Flier E, Flier JS. Remodeling of the arcuate nucleus energy-balance circuit is inhibited in obese mice. J Clin Invest 2012; 122: 142-152.
89. Huang S, Rutkowsky JM, Snodgrass RG, Ono-Moore KD, Schneider DA, Newman JW et al. Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways. J Lipid Res 2012; 53: 2002-2013.
90. Milanski M, Degasperi G, Coope A, Morari J, Denis R, Cintra DE et al. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J Neurosci 2014; 29: 359-370.
91. Wang Z, Liu D, Wang F, Liu S, Zhao S, Ling EA et al. Saturated fatty acids activate microglia via Toll-like receptor 4/NF-κB signalling. Br J Nutr 2012; 107: 229-241.
92. Reis WL, Yi CY, Gao Y, Tschöp MH, Stern JE. Brain innate immunity regulates hypothalamic arcuate neuronal activity and feeding behavior. Endocrinology 2015; 156: 1303-1315.
93. Xiaolei M, Helgason E, Phung QT, Quan CL, Iyer RS, Lee MW et al. Molecular basis of Tank-binding kinase 1 activation by transautophosphorylation. Proc Natl Acad Sci USA 2012; 109: 9378-9383.
94. Pomerantz JL, Baltimore D. NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J 1999; 18: 6694-6704.
95. Muñoz MC, Giani JF, Mayer MA, Toblli JE, Turyn D, Dominici FP. TANK-binding kinase 1 mediates phosphorylation of insulin receptor at serine residue 994: a potential link between inflammation and insulin resistance. J Endocrinol 2009; 201: 185-197.
96. Reilly SM, Chiang SH, Decker SJ, Chang L, Uhm M, Larsen MJ et al. An inhibitor of the protein kinases TBK1 and IKK-epsilon improves obesity-related metabolic dysfunctions in mice. Nat Med 2013; 19: 313-321.
97. Delint RI, Maldonado RR, Torre VI, Fuentes ML, Garza OL, Tovar A et al. Genetic obesity alters recruitment of TANK-binding kinase 1 and AKT into hypothalamic lipid rafts domains. Neurochem Int 2015; 80: 23-32.
98. Weissmann L, Quaresma PG, Santos AC, de Matos AH, Pascoal VD, Zanotto TM et al. IKKϵ is key to induction of insulin resistance in the hypothalamus, and its inhibition reverses obesity. Diabetes 2014; 63: 3334-3345.
99. Reilly SM, Ahmadian M, Zamarron BF, Chang L, Uhm M, Poirier B et al. A subcutaneous adipose tissue-liver signalling axis controls hepatic gluconeogenesis. Nat Commun 2015; 12: 6047.
100. Barreto-Vianna AR, Aguila MB, Mandarim-de-Lacerda CA. Effects of liraglutide in hypothalamic arcuate nucleus of obese mice. Obesity 2016; 24: 626-633.
101. Naznin F, Sakoda H, Okada T, Tsubouchi H, Waise TM, Arakawa K et al. Canagliflozin, a sodium glucose cotransporter 2 inhibitor, attenuates obesity-induced inflammation in the nodose ganglion, hypothalamus, and skeletal muscle of mice. Eur J Pharmacol 2016; 19: 37-44.
102. Oh-I S, Thaler JP, Ogimoto K, Wisse BE, Morton GJ, Schwartz MW. Central administration of interleukin-4 exacerbates hypothalamic inflammation and weight gain during high-fat feeding. Am J Physiol Endocrinol Metab 2010; 299: E47-E53.
103. Benzler J, Ganjam GK, Pretz D, Oelkrug R, Koch CE, Legler K et al. Central inhibition of IKKβ/NF-κB signaling attenuates high-fat diet-induced obesity and glucose intolerance. Diabetes 2015; 64: 2015-2027.
104. Ropelle ER, Flores MB, Cintra DE, Rocha GZ, Pauli JR, Morari J et al. IL-6 and IL-10 anti-inflammatory activity links exercise to hypothalamic insulin and leptin sensitivity through IKKbeta and ER stress inhibition. PLoS Biol 2010; 8, pii e1000465.
105. Leinonen E, Hurt-Camejo E, Wiklund O, Hulten LM, Hiukka A, Taskinen MR. Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes. Atherosclerosis 2003; 166: 387-394.